Lecap Asset Management Ltd. increased its position in shares of Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 70.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,530 shares of the financial services provider's stock after buying an additional 4,337 shares during the period. Lecap Asset Management Ltd.'s holdings in Houlihan Lokey were worth $1,701,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Elevation Point Wealth Partners LLC purchased a new position in Houlihan Lokey during the first quarter valued at $619,000. QRG Capital Management Inc. lifted its holdings in Houlihan Lokey by 9.7% during the first quarter. QRG Capital Management Inc. now owns 4,987 shares of the financial services provider's stock valued at $805,000 after purchasing an additional 439 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in Houlihan Lokey by 80.9% during the fourth quarter. Jones Financial Companies Lllp now owns 5,638 shares of the financial services provider's stock valued at $979,000 after purchasing an additional 2,521 shares in the last quarter. Sowell Financial Services LLC purchased a new position in Houlihan Lokey during the first quarter valued at $313,000. Finally, Harbor Capital Advisors Inc. purchased a new position in Houlihan Lokey during the first quarter valued at $3,297,000. 78.07% of the stock is owned by hedge funds and other institutional investors.
Houlihan Lokey Trading Up 0.0%
Houlihan Lokey stock traded up $0.00 during midday trading on Friday, hitting $182.75. 874,232 shares of the stock were exchanged, compared to its average volume of 353,250. Houlihan Lokey, Inc. has a fifty-two week low of $133.48 and a fifty-two week high of $192.10. The stock has a market capitalization of $12.75 billion, a price-to-earnings ratio of 31.40 and a beta of 0.83. The stock's 50-day simple moving average is $171.90 and its 200 day simple moving average is $170.06.
Houlihan Lokey (NYSE:HLI - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.61 by $0.35. The firm had revenue of $666.42 million during the quarter, compared to analysts' expectations of $628.25 million. Houlihan Lokey had a net margin of 16.73% and a return on equity of 21.61%. Houlihan Lokey's revenue was up 28.0% compared to the same quarter last year. During the same period last year, the business earned $1.27 earnings per share. Equities analysts anticipate that Houlihan Lokey, Inc. will post 5.98 EPS for the current fiscal year.
Houlihan Lokey Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Sunday, June 15th. Investors of record on Monday, June 2nd were paid a dividend of $0.60 per share. This is an increase from Houlihan Lokey's previous quarterly dividend of $0.57. This represents a $2.40 annualized dividend and a yield of 1.31%. The ex-dividend date was Monday, June 2nd. Houlihan Lokey's dividend payout ratio is presently 41.24%.
Insider Buying and Selling
In other Houlihan Lokey news, General Counsel Christopher M. Crain sold 500 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $173.02, for a total transaction of $86,510.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Scott L. Beiser sold 8,008 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $178.71, for a total transaction of $1,431,109.68. The disclosure for this sale can be found here. 23.68% of the stock is owned by insiders.
Analyst Ratings Changes
A number of brokerages have recently commented on HLI. Wall Street Zen cut shares of Houlihan Lokey from a "buy" rating to a "hold" rating in a research report on Friday. Morgan Stanley reiterated an "overweight" rating and issued a $192.00 target price (up from $159.00) on shares of Houlihan Lokey in a research report on Monday, June 23rd. Keefe, Bruyette & Woods increased their target price on shares of Houlihan Lokey from $183.00 to $185.00 and gave the company a "market perform" rating in a research report on Monday, May 12th. Finally, Wells Fargo & Company increased their target price on shares of Houlihan Lokey from $170.00 to $185.00 and gave the company an "overweight" rating in a research report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $192.20.
View Our Latest Research Report on Houlihan Lokey
Houlihan Lokey Company Profile
(
Free Report)
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
Recommended Stories

Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.